We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rising Diagnosis of Viral Meningitis Is Often Delayed

By LabMedica International staff writers
Posted on 10 Jul 2018
As the incidence of bacterial meningitis decreases, the proportion of meningitis cases caused by viruses is increasing and the use of molecular diagnostics has also led to increased recognition of neurological viral infections.

Identification of the cause of meningitis is important to improve clinical care, including reducing unnecessary use of antibiotics and antivirals. More...
Patients with suspected viral meningitis are often treated with antibiotics while a diagnosis of bacterial meningitis is excluded, which results in patients receiving long courses of antibiotics and can extend their hospital stay.

A large team of scientists working with the University of Liverpool (Liverpool, UK) carried out a multicenter prospective observational cohort study of adults with suspected meningitis at 42 hospitals across England. The investigators enrolled 1,126 patients were enrolled between September 30, 2011, and September 30, 2014. There were 638 (57%) patients who had meningitis: 231 (36%) cases were viral, 99 (16%) were bacterial and 267 (42%) had an unknown cause. 41 (6%) cases had other causes.

The team identified cerebrospinal fluid (CSF) samples with a leucocyte count of more than 4 × 106 cells/L from laboratory records and classified them according to pathogen identified (or unknown if none was found). All CSF samples were examined by microscopy and culture. CSF polymerase chain reaction (PCR) was done in the admitting hospitals, regional diagnostic centers, or the University of Liverpool, to test for herpes simplex virus types 1 and 2, varicella zoster virus, and enteroviruses, as well as Streptococcus pneumoniae and Neisseria meningitidis, following national recommendations. They applied a proportional inflation, based on the total number of cases (those recruited and those missed) divided by the actual number recruited into the northwest sites in the prospective study, to the initial estimated northwest incidence data.

The team found that found that diagnosis of meningitis was often delayed due to unnecessary brain scans being performed before lumbar puncture, which is the essential investigation to determine the cause of the illness. The majority of patients (81%) had a brain scan and 70% of those took place before lumbar puncture, otherwise known as a spinal tap. Overall, the specific virus or bacteria causing the illness was not identified for 43% of patients.

The authors concluded that their findings demonstrated that viruses are the predominant cause of adult meningitis in the UK, with enteroviruses and herpesviruses responsible for the majority of cases for which a cause is found. Michael Griffiths, BMedSci, BMBS, DPhil, a senior clinical lecturer and a co-author of the study, said, “Diagnosing a specific cause of meningitis quickly is key to getting patients on the right antibiotics, if needed, or avoiding unnecessary antibiotics in those with viral meningitis. Once viral meningitis has been diagnosed, efforts should focus on treatment of the symptoms and expediting discharge from hospital, which would be less distressing for patients and ease pressures on the NHS. The study was published on June 29, 2018, in the journal The Lancet Infectious Diseases.

Related Links:
University of Liverpool


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The Elecsys pTau-181 test helps rule out Alzheimer’s disease in symptomatic patients aged 55 and older by identifying absence of amyloid pathology (photo courtesy of Roche)

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care

Timely evaluation of cognitive symptoms in primary care is often limited by restricted access to specialized diagnostics and invasive confirmatory procedures. Clinicians need accessible tools to determine... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.